Literature DB >> 28826679

Worldwide Burden of and Trends in Mortality From Gallbladder and Other Biliary Tract Cancers.

Lindsey A Torre1, Rebecca L Siegel2, Farhad Islami2, Freddie Bray3, Ahmedin Jemal2.   

Abstract

BACKGROUND & AIMS: Gallbladder cancer has a low rate of survival, a unique geographic distribution, and is associated with lifestyle factors that have changed in recent decades. We investigated recent mortality patterns and trends worldwide.
METHODS: We collected data from the World Health Organization's Cancer Mortality Database to examine sex-specific, age-standardized rates of death from gallbladder and other biliary tract cancers (excluding intrahepatic bile duct cancer; International Classification of Diseases, 9th revision, code 156, or International Classification of Diseases, 10th revision, code C23-24). We compiled cross-sectional rates of mortality from 2009 through 2013 from 50 countries, and also trends over time from 1985 through 2014, using joinpoint regression analysis of data from 45 countries.
RESULTS: Among women, from 2009 through 2013, there was a 26-fold variation in rates of mortality from gallbladder and other biliary tract cancers; rates ranged from 0.8 deaths per 100,000 in South Africa to 21.2 deaths per 100,000 in Chile. Among men, rates varied 16-fold, from 0.6 deaths per 100,000 in the United Kingdom and Ireland to 9.9 deaths per 100,000 in Chile. Rates of mortality were higher for women than men in 22 of 48 countries for which comparison was possible. Mortality rates are decreasing in most countries, with decreases in the highest-risk populations of 2% or more annually (except Croatia). However, rates continued their long-term increase in Greece, by 1.4% annually in women and 4.7% annually in men from 1985 through 2012, and began increasing in the mid-2000s by 1.9% or more annually in women in the United Kingdom and The Netherlands and in men in Germany.
CONCLUSIONS: In an analysis of the World Health Organization's Cancer Mortality Database, we found that rates of death from gallbladder and other biliary tract cancers are decreasing in most countries but increasing in some high-income countries following decades of decline. These emerging trends may reflect lifestyle changes, such as increases in excess body weight.
Copyright © 2018 AGA Institute. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Cancer Registries; Epidemiology; Gastrointestinal Cancer; Surveillance

Mesh:

Year:  2017        PMID: 28826679     DOI: 10.1016/j.cgh.2017.08.017

Source DB:  PubMed          Journal:  Clin Gastroenterol Hepatol        ISSN: 1542-3565            Impact factor:   11.382


  23 in total

1.  Cancer mortality rates among US and foreign-born individuals: United States 2005-2014.

Authors:  Benjamin D Hallowell; Meheret Endeshaw; Matthew T McKenna; Virginia Senkomago; Hilda Razzaghi; Mona Saraiya
Journal:  Prev Med       Date:  2019-06-18       Impact factor: 4.018

2.  Anthropometric Risk Factors for Cancers of the Biliary Tract in the Biliary Tract Cancers Pooling Project.

Authors:  Sarah S Jackson; Alison L Van Dyke; Bin Zhu; Ruth M Pfeiffer; Jessica L Petrick; Hans-Olov Adami; Demetrius Albanes; Gabriella Andreotti; Laura E Beane Freeman; Amy Berrington de González; Julie E Buring; Andrew T Chan; Yu Chen; Gary E Fraser; Neal D Freedman; Yu-Tang Gao; Susan M Gapstur; J Michael Gaziano; Graham G Giles; Eric J Grant; Francine Grodstein; Patricia Hartge; Mazda Jenab; Cari M Kitahara; Synnove F Knutsen; Woon-Puay Koh; Susanna C Larsson; I-Min Lee; Linda M Liao; Juhua Luo; Emma E McGee; Roger L Milne; Kristine R Monroe; Marian L Neuhouser; Katie M O'Brien; Ulrike Peters; Jenny N Poynter; Mark P Purdue; Kim Robien; Dale P Sandler; Norie Sawada; Catherine Schairer; Howard D Sesso; Tracey G Simon; Rashmi Sinha; Rachael Z Stolzenberg-Solomon; Shoichiro Tsugane; Renwei Wang; Elisabete Weiderpass; Stephanie J Weinstein; Emily White; Alicja Wolk; Jian-Min Yuan; Anne Zeleniuch-Jacquotte; Xuehong Zhang; Katherine A McGlynn; Peter T Campbell; Jill Koshiol
Journal:  Cancer Res       Date:  2019-05-21       Impact factor: 12.701

3.  GIDB: a knowledge database for the automated curation and multidimensional analysis of molecular signatures in gastrointestinal cancer.

Authors:  Ying Wang; Yueqian Wang; Shuangkuai Wang; Yuantao Tong; Ling Jin; Hui Zong; Rongbin Zheng; Jinxuan Yang; Zeyu Zhang; En Ouyang; Mengyan Zhou; Xiaoyan Zhang
Journal:  Database (Oxford)       Date:  2019-01-01       Impact factor: 3.451

Review 4.  Primary Sclerosing Cholangitis: A Concise Review of Diagnosis and Management.

Authors:  Zachary P Fricker; David R Lichtenstein
Journal:  Dig Dis Sci       Date:  2019-02-06       Impact factor: 3.199

5.  Diagnostic performance and inter-observer variability to differentiate between T1- and T2-stage gallbladder cancers using multi-detector row CT.

Authors:  Yong Jae Kwon; Kyoung Doo Song; Seong Eun Ko; Jeong Ah Hwang; Minji Kim
Journal:  Abdom Radiol (NY)       Date:  2022-02-22

6.  Risk Stratification of Cholangiocarcinoma Patients Presenting with Jaundice: A Retrospective Analysis from a Tertiary Referral Center.

Authors:  Ana Lleo; Francesca Colapietro; Patrick Maisonneuve; Monia Aloise; Vincenzo Craviotto; Roberto Ceriani; Lorenza Rimassa; Salvatore Badalamenti; Matteo Donadon; Vittorio Pedicini; Alessandro Repici; Luca Di Tommaso; Antonio Voza; Guido Torzilli; Alessio Aghemo
Journal:  Cancers (Basel)       Date:  2021-04-25       Impact factor: 6.639

7.  Gallbladder and extrahepatic bile duct cancers in the Americas: Incidence and mortality patterns and trends.

Authors:  Adalberto Miranda-Filho; Marion Piñeros; Catterina Ferreccio; Volkan Adsay; Isabelle Soerjomataram; Freddie Bray; Jill Koshiol
Journal:  Int J Cancer       Date:  2020-01-21       Impact factor: 7.316

8.  Circulating tumor cell levels and carcinoembryonic antigen: An improved diagnostic method for lung adenocarcinoma.

Authors:  Cheng Ding; Xiaofei Zhou; Chun Xu; Jun Chen; Shen Ju; Tengfei Chen; Zhipan Liang; Zihan Cui; Chang Li; Jun Zhao
Journal:  Thorac Cancer       Date:  2018-09-04       Impact factor: 3.500

9.  Osthole inhibits the progression of human gallbladder cancer cells through JAK/STAT3 signal pathway both in vitro and in vivo.

Authors:  Tian Le Zou; Hong Fei Wang; Tai Ren; Zi Yu Shao; Rui Yan Yuan; Yuan Gao; Yi Jian Zhang; Xu An Wang; Ying Bin Liu
Journal:  Anticancer Drugs       Date:  2019-11       Impact factor: 2.248

Review 10.  Epidemiology of gallbladder cancer.

Authors:  Prashanth Rawla; Tagore Sunkara; Krishna Chaitanya Thandra; Adam Barsouk
Journal:  Clin Exp Hepatol       Date:  2019-05-23
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.